Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf vs Prograf PK in Transplant Recipients
NCT01332201Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2011
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, open-label trial of tacrolimus + Wuzhi capsule in heart transplantation, lung transplantation and pancreas transplantation (2 arms), sponsored by Astellas Pharma. Primary endpoint: Steady state systemic exposure (AUC 0-24h) at Day 42. Started Jul 2011; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
heart transplantationlung transplantationpancreas transplantation
Beyond the preview
Go deeper on NCT01332201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01332201.